Yuki Nakano

Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan

Yuki Nakano, Makoto Kurano, Yoshifumi Morita et al. · Scientific Reports · 2021 · 64 citations · Full text

Response kinetics of different classes of antibodies to SARS-CoV2 infection in the Japanese population: The IgA and IgG titers increased earlier than the IgM titers

Makoto Kurano, Yoshifumi Morita, Yuki Nakano et al. · International Immunopharmacology · 2021 · 20 citations · Full text

Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan

Rin Yokoyama, Makoto Kurano, Yoshifumi Morita et al. · PLoS ONE · 2021 · 19 citations · Full text

Viral Diagnostics, Pcr Methods, Immunology +17

Association of the Serum Levels of the Nucleocapsid Antigen of SARS-CoV-2 With the Diagnosis, Disease Severity, and Antibody Titers in Patients With COVID-19: A Retrospective Cross-Sectional Study

Rin Yokoyama, Makoto Kurano, Yuki Nakano et al. · Frontiers in Microbiology · 2021 · 14 citations · Full text

Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients

Makoto Kurano, Hiroko Ohmiya, Yoshiro Kishi et al. · Frontiers in Immunology · 2022 · 13 citations · Full text

Maximum Severity, Machine Learning, Viral Diagnostics +17